Combination of Arginine Depletion and Chemotherapy in Thoracic Malignancies
نویسندگان
چکیده
منابع مشابه
Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies
OBJECTIVE To investigate whether the depletion of nerve growth factor (NGF) is associated with the development of chemotherapy-induced peripheral neuropathy (CIPN) in patients with hematologic malignancy. METHODS We prospectively enrolled hematologic cancer patients who had a plan to receive bortezomib, thalidomide, or vincristine. Baseline NGF levels were measured within one week before the ...
متن کاملPET: other thoracic malignancies
The vast majority of esophageal cancers are fluorodeoxyglucose (FDG) avid; the primary use for positron emission tomography (PET) in patients with esophageal cancer is in the detection of distant metastases, because known distant metastatic disease precludes surgical resection. High standardized uptake values (SUVs) may be predictive of poor prognosis. PET findings may be used to assess therapy...
متن کاملCombination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience
In vitro studies have demonstrated that cancer-specific T cell cytotoxicity can be induced both ex vivo and in vivo, but this therapeutic strategy should probably be used as an integrated part of a cancer treatment regimen. Initial chemotherapy should be administered to reduce the cancer cell burden and disease-induced immune defects. This could be followed by autologous stem cell transplantati...
متن کاملChemotherapy of Gastrointestinal Malignancies.
Beginning with esophageal cancer of both the adeno and squamous variety, it would appear that combined modality therapy is here to stay. Most cancer programs now advocate chemotherapy, usually cisplatin and 5-fluorouracil together with radiation therapy, prior to definitive esophagectomy for localized disease. An exciting advance is the discovery of the activity of paclitaxel in this setting, a...
متن کاملPhase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies.
PURPOSE Our first objective was to evaluate the feasibility of administering a combination of Doxil, a pegylated liposome formulation of doxorubicin, and cisplatin and to determine the maximum tolerated dose of the combination. A secondary objective was to examine Doxil peak and 7-day postinjection plasma levels at the various dose levels tested. METHODS Patients with advanced solid tumors we...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Oncology
سال: 2017
ISSN: 0732-183X,1527-7755
DOI: 10.1200/jco.2017.72.7305